Coactiv+ - no news, no sales update, total radio silence....It is amazing to see that KNE did not announce it's first sale of Coactiv+ in the USA (through Progenacare) yet. The deal with Progenacare was made prior to the FDA approval so, one would imagine that Progenacare customers were told in advance that the product was coming and still no news. KNE did not even bother to do a press release to confirm the receipt of the 500K upfront payment from Progenacare. I understand that the KNE team is rather small but investors communication is critical for a biotech of that size in order to keep the investment community interest and we fail big time on that front.
The above being said, it looks like we are on the right path in regards to products development, approval, trials, etc.... but need more to get the investment community interest.
GLTA